- Home
- CUE vs BZFD Comparison
CUE vs BZFD Comparison
Compare CUE & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- BZFD
- Stock Information
- Founded
- CUE 2014
- BZFD 2006
- Country
- CUE United States
- BZFD United States
- Employees
- CUE N/A
- BZFD N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- BZFD Movies/Entertainment
- Sector
- CUE Health Care
- BZFD Consumer Discretionary
- Exchange
- CUE Nasdaq
- BZFD Nasdaq
- Market Cap
- CUE 56.1M
- BZFD 64.1M
- IPO Year
- CUE 2018
- BZFD N/A
- Fundamental
- Price
- CUE $0.86
- BZFD $1.72
- Analyst Decision
- CUE Strong Buy
- BZFD
- Analyst Count
- CUE 2
- BZFD 0
- Target Price
- CUE $3.00
- BZFD N/A
- AVG Volume (30 Days)
- CUE 220.6K
- BZFD 288.7K
- Earning Date
- CUE 11-13-2025
- BZFD 11-11-2025
- Dividend Yield
- CUE N/A
- BZFD N/A
- EPS Growth
- CUE N/A
- BZFD N/A
- EPS
- CUE N/A
- BZFD 0.25
- Revenue
- CUE $8,286,000.00
- BZFD $194,178,000.00
- Revenue This Year
- CUE N/A
- BZFD $6.87
- Revenue Next Year
- CUE N/A
- BZFD $6.21
- P/E Ratio
- CUE N/A
- BZFD $6.78
- Revenue Growth
- CUE N/A
- BZFD 1.38
- 52 Week Low
- CUE $0.54
- BZFD $1.61
- 52 Week High
- CUE $1.99
- BZFD $5.68
- Technical
- Relative Strength Index (RSI)
- CUE 58.69
- BZFD 32.15
- Support Level
- CUE $0.71
- BZFD $1.66
- Resistance Level
- CUE $0.73
- BZFD $1.80
- Average True Range (ATR)
- CUE 0.04
- BZFD 0.06
- MACD
- CUE 0.01
- BZFD 0.00
- Stochastic Oscillator
- CUE 95.92
- BZFD 7.69
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.